Results 111 to 120 of about 940,684 (303)
Clinical Validation of Plasma p‐217tau in Neurological Diseases
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective Plasma p‐217tau is a minimally invasive but specific biomarker for diagnosing Alzheimer's disease (AD). However, its disease specificity remains to be clinically evaluated. We validated the reliability of the p‐217tau biomarker in 12 other neurological diseases.
Takeshi Kawarabayashi +13 more
wiley +1 more source
Imaging Studies of Aging, Neurodegenerative Disease, and Alcoholism. [PDF]
, 1995 Neurodegenerative diseases such as Alzheimers disease, disorders such as alcoholism, and the aging process can lead to impaired cognitive function and dementia.
Eberling, Jamie, JAGUST, William J
core
Von Economo Neuron Loss in Frontotemporal Dementia: A Meta‐Analysis of Neuropathological Studies
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Von Economo neurons (VENs) have been reported to be vulnerable to neurodegeneration in frontotemporal dementia (FTD), particularly the behavioral variant (bvFTD), but these findings have not been systematically assessed across independent brain banks.
Daniel Talmasov +2 more
wiley +1 more source
Addressing the Spiritual Needs of People Aging with Dementia and/or Lifelong Disabilities [PDF]
, 2018 Educational Objectives 1. Present the need for spiritual care as part of holistic care for people living with dementia and/or lifelong disabilities. 2. Distinguish the difference between spirituality and religion. 3.
Berry, Kathy Fogg
core +1 more source
Functional neuroanatomy of auditory scene analysis in Alzheimer's disease
NeuroImage: Clinical, 2015 Auditory scene analysis is a demanding computational process that is performed automatically and efficiently by the healthy brain but vulnerable to the neurodegenerative pathology of Alzheimer's disease.
Hannah L. Golden +7 more
doaj +1 more source
Senile Dementia and Presenile Dementia
The Tohoku Journal of Experimental Medicine, 1990 Neurotransmitters including acetylcholine, dopamine, norepinephrine, serotonin, GABA and vasopressin were examined in control subjects and patients with Alzheimer-type dementia, involving presenile and senile dementia. Neurotransmitters exhibited various mode of changes with aging.
openaire +3 more sources
Arthritis Care &Research, EarlyView.Objective We aimed to test the efficacy of personalized treatment of older veterans with chronic low back pain (CLBP) delivered by Aging Back Clinics (ABCs) as compared with usual care (UC). Methods Two hundred ninety‐nine veterans aged 65 to 89 with CLBP from three Veterans Affairs (VA) medical centers underwent baseline testing, randomization to ABC ...
Debra K. Weiner +9 more
wiley +1 more source
Dementia-Friendly Resources [PDF]
, 2019 While dementia caregiving challenges continue for individual caregivers and communities, Alzpossible.org and Dementia Friendly America (dfamerica.org) can offer immediate support and a hopeful ...
Ansello, Edward F.
core +1 more source
BMC Public HealthBackground South Asian migrants are one of the fastest-growing populations in Australia, particularly in the southern island state of Tasmania. However, there is limited research evaluating their modifiable dementia risk factors. This study aimed to fill
Mohammed Shoaib Hamrah +8 more
doaj +1 more source
Alzheimer’s Research & Therapy, 2018 Background Cerebrospinal fluid (CSF) biomarkers are increasingly being used to support a diagnosis of Alzheimer’s disease (AD). Their clinical utility for differentiating AD from non-AD neurodegenerative dementias, such as dementia with Lewy bodies (DLB)
Ross W. Paterson +19 more
doaj +1 more source